Sidoti analyst Anthony Lebiedzinski upgraded Prestige Consumer (PBH) to Buy from Neutral with an $80 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBH:
- Buy Rating for Prestige Consumer Healthcare: Strategic Initiatives and Resilience Drive Growth Potential
- Prestige Consumer Healthcare’s Cautious Earnings Call Outlook
- Prestige Consumer price target lowered to $100 from $105 at Canaccord
- Prestige Consumer Healthcare’s Q1 Earnings and Strategic Moves
- Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion
